Precision Healthcare Innovator Brian Meshkin and Leading Litigation Law Firm, Plante Huguenin Lebovic Kahn LLP, Sue Federal Government After Discredited Prosecution Ruined Genetic Test Company Essential to Combating America's Opioid Crisis

Mon, 16 Sep 2024 18:26:00 -0400

The $700 million lawsuit against the United States seeks justice pertaining to the Department of Justice's gross misconduct in investigating and prosecuting predictive healthcare innovator Brian Meshkin and his company, Proove Biosciences. Proove offered critical medical tests to evaluate genetic and non-genetic factors in chronic pain, including one that could predict with 96.7% accuracy a patient's risk for opioid addiction, a significant concern in the ongoing opioid epidemic. As CEO of...

Proove Genomics Perseveres with Relaunch, Reinforcing Their Position as Leader in Personalized and Predictive Pain Diagnostics

Mon, 15 Jul 2024 13:49:00 -0400

Arlington, Texas--(Newsfile Corp. - July 15, 2024) - Health Technology Executive and Award-Winning Social Entrepreneur, Brian Meshkin relaunches Proove Genomics, continuing the mission to provide personalized and predictive pain management solutions to Americans in dire need. Fortified by the most advanced tools in genetics and information technology, and supported by the world's largest clinical-genetic data bank for pain and orthopedics, with over 153,000 patients and 28 billion data points,...

Proove Genomics News Releases

Precision Healthcare Innovator Brian Meshkin and Leading Litigation Law Firm, Plante Huguenin Lebovic Kahn LLP, Sue Federal Government After Discredited Prosecution Ruined Genetic Test Company Essential to Combating America's Opioid Crisis

Proove Genomics Perseveres with Relaunch, Reinforcing Their Position as Leader in Personalized and Predictive Pain Diagnostics